-+ 0.00%
-+ 0.00%
-+ 0.00%

Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress

PUBT·08/24/2026 12:55:16
Listen to the news
Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress
  • Anixa Biosciences will attend the 2026 Cantor Fitzgerald Global Healthcare Conference in New York on Sept. 9-11, 2026.
  • A management presentation is scheduled for Sept. 11, 2026 at 8:00 a.m. ET.
  • Update will cover Phase 1 breast cancer vaccine results, with immune responses in 74% of participants.
  • Discussion will also include lira-cel ovarian cancer CAR-T dosing in the fifth cohort, with no dose-limiting toxicities reported.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608240855PR_NEWS_USPR_____LA31702) on August 24, 2026, and is solely responsible for the information contained therein.